| Pharmaceutical Information |
| Drug Name |
Hyaluronidase (ovine) |
| Drug ID |
BADD_D01080 |
| Description |
Highly purified sheep hyaluronidase for administration by injection into the vitreous of the eye. |
| Indications and Usage |
For increase of absorption and distribution of other injected drugs and for rehydration. |
| Marketing Status |
approved; investigational |
| ATC Code |
B06AA03 |
| DrugBank ID |
DB00070
|
| KEGG ID |
D04455; D06604; D04456
|
| MeSH ID |
D006821
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D04GPZ
|
| NDC Product Code |
Not Available |
| UNII |
64R4OHP8T0
|
| Synonyms |
Hyaluronoglucosaminidase | Hyaluronidase | Hyaglosidase | Hyaluronate Hydrolase | Hydrolase, Hyaluronate | Duran-Reynals Permeability Factor | Duran Reynals Permeability Factor | Factor, Duran-Reynals Permeability | Permeability Factor, Duran-Reynals | GL Enzyme | Wydase |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
488712-31-8 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Anaphylactic reaction | 24.06.03.006; 10.01.07.001 | - | - | | | Angioedema | 22.04.02.008; 23.04.01.001; 10.01.05.009 | - | - | Not Available | | Hypersensitivity | 10.01.03.003 | - | - | | | Oedema | 08.01.07.006; 14.05.06.010 | - | - | Not Available | | Urticaria | 23.04.02.001; 10.01.06.001 | - | - | |
|
The 1th Page
1
Total 1 Pages
|
|
